News

"We're just scratching the surface": OTN leader named to Canada's Top 40 under 40

"We're just scratching the surface": OTN leader named to Canada's Top 40 under 40

OTN Scientific Director Rob Lennox discusses the growing impact of ocean tracking and why scientists are only beginning to unlock the potential of the data they collect.  Read more.

Featured News

Anna Wood
Tuesday, September 15, 2026
Thousands of students turned donated goods into practical finds during the Free Store's back-to-school rush, showcasing the growing demand for affordable, sustainable shopping on campus.
Darcy MacPhail
Wednesday, September 16, 2026
Under new Director Rachelle McKay, TYP welcomes a new cohort, unveils an upgraded home base, and builds on a legacy stretching back more than five decades.
Mary-Eleanor Power
Wednesday, September 2, 2026
Designed around real-world challenges facing firefighters, the program supports professional growth and helps enhance emergency response capacity in communities throughout Nova Scotia.

Archives - News

Matt Reeder
Monday, November 28, 2022
色妹妹直播's Accessibility Plan, released this past summer, lays out a detailed roadmap for ensuring the university meets Nova Scotia's goal of being fully accessible by 2030.
Andrew Riley
Thursday, November 24, 2022
Last night鈥檚 20th annual Discovery Awards, co-presented by 色妹妹直播, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Staff
Wednesday, November 23, 2022
On Tuesday, the Board of Governors approved a new international tuition model for future students featuring a tuition guarantee and fees better aligned with Dal鈥檚 national peers 鈥� all of which is poised to bring significant investments in Dal鈥檚 student experience.
Staff
Wednesday, November 23, 2022
Cheryl Fraser, a two-time Dal alum who is current is currently Chief Talent Officer and Vice-President Communications at Crombie REIT, has been appointed Chair of the 色妹妹直播 Board of Governors for a three-year term.
Alison Auld
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.